Risk factors
INVO Fertility (IVF) risk factors
Item 1A of every INVO Fertility, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors52 risks6 new53 dropped13 reworded
Expansion strategy now emphasizes acquiring profitable U.S. fertility clinics, but targets, financing, and integration remain uncertain.
Filed Jun 02, 2026 - FY2024 10-K risk factors99 risks
INVO Fertility faces substantial accumulated net losses, ongoing liquidity concerns, and a high degree of operational leverage tied to debt and acquisitions like WFI and NAYA Therapeutics. Regulatory compliance across FDA medical device standards and healthcare fraud laws significantly impacts commercialization efforts and clinical trials.
Filed Apr 30, 2025